trending Market Intelligence /marketintelligence/en/news-insights/trending/dnhcvq-eb-quqvadmgbyta2 content esgSubNav
In This List

Oncimmune names chief medical, strategy officer

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Oncimmune names chief medical, strategy officer

Oncimmune Holdings plc named Adam Hill as its chief medical and chief strategy officer.

Hill, who will assume the positions April 9, most recently worked with McLaren Applied Technologies in a similar capacity.

He is also the former chief medical officer of Sectra AB.

Nottingham, U.K.-based Oncimmune is looking to commercialize its EarlyCDT platform to detect cancer.